News Releases News Releases IR Sub Menu - News & Events News ReleasesEvents & Presentations News Releases Year None202220212020201920182017201620152014 Pear Announces Health Equity Data Showing Similar Engagement with reSET-O® Across US Geographic Regions Presented at APA Annual Meeting May 24, 2022 Pear Therapeutics to Host Inaugural Virtual Investor Day on June 6, 2022 May 19, 2022 Pear Therapeutics Reports First Quarter 2022 Financial Results May 16, 2022 Pear Therapeutics Announces the Inclusion of QuickMD in Its Telehealth Provider Experience Initiative May 12, 2022 Pear Therapeutics to Participate in the 17th Annual Needham Technology & Media Conference May 11, 2022 Pear Therapeutics to Participate in the Bank of America 2022 Healthcare Conference May 3, 2022 Pear Therapeutics to Issue First Quarter 2022 Financial Results on Monday, May 16, 2022 May 2, 2022 Pear Therapeutics to Present at 2022 Rx and Illicit Drug Summit April 18, 2022 Pear Therapeutics Receives Safer Technologies Program (STeP) Designation from FDA for Product Candidate to Treat Acute and Chronic Pain April 13, 2022 Pear Therapeutics to Participate in Upcoming Investor Conferences April 5, 2022 Pagination Current page 1 Page 2 Page 3 Next page next › Last page last » Displaying 1 - 10 of 26
News Releases Year None202220212020201920182017201620152014 Pear Announces Health Equity Data Showing Similar Engagement with reSET-O® Across US Geographic Regions Presented at APA Annual Meeting May 24, 2022 Pear Therapeutics to Host Inaugural Virtual Investor Day on June 6, 2022 May 19, 2022 Pear Therapeutics Reports First Quarter 2022 Financial Results May 16, 2022 Pear Therapeutics Announces the Inclusion of QuickMD in Its Telehealth Provider Experience Initiative May 12, 2022 Pear Therapeutics to Participate in the 17th Annual Needham Technology & Media Conference May 11, 2022 Pear Therapeutics to Participate in the Bank of America 2022 Healthcare Conference May 3, 2022 Pear Therapeutics to Issue First Quarter 2022 Financial Results on Monday, May 16, 2022 May 2, 2022 Pear Therapeutics to Present at 2022 Rx and Illicit Drug Summit April 18, 2022 Pear Therapeutics Receives Safer Technologies Program (STeP) Designation from FDA for Product Candidate to Treat Acute and Chronic Pain April 13, 2022 Pear Therapeutics to Participate in Upcoming Investor Conferences April 5, 2022 Pagination Current page 1 Page 2 Page 3 Next page next › Last page last » Displaying 1 - 10 of 26